Skip to main content
TipRanks
Go Ultimate75% OFF

EyePoint Pharmaceuticals (PV3B) Q4 2018 Earnings Report

1 Followers

DE:PV3B Q4 2018 EPS Results

Actual EPS
-EUR 5.65
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 1.46

DE:PV3B Q4 2018 Revenue Results

Actual Revenue
EUR 651.78K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2018
Date
09/12/2018
Time
TBA
Conference Call
Wednesday, September 12, 2018
DE:PV3B Upcoming Earnings

EyePoint Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q4 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:PV3B Earnings History

DE:PV3B earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.63--0.74――
Nov 12, 20262026 (Q3)-0.85-0.98-0.77-25.88% (-0.20)
Aug 05, 20262026 (Q2)-0.90-0.99-0.77-28.24% (-0.22)
May 06, 20262026 (Q1)-0.73-0.90-0.59-52.31% (-0.31)
Mar 04, 20262025 (Q4)-0.68-0.74-0.58-26.56% (-0.15)
Nov 05, 20252025 (Q3)-0.70-0.77-0.49-57.41% (-0.28)
Aug 06, 20252025 (Q2)-0.75-0.77-0.53-46.55% (-0.25)
May 07, 20252025 (Q1)-0.61-0.59-0.5-18.18% (-0.09)
Mar 05, 20252024 (Q4)-0.44-0.58-0.3-93.94% (-0.28)
Nov 07, 20242024 (Q3)-0.50-0.49-0.3-63.64% (-0.19)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed